Pituitary adenylate cyclase-activating polypeptide (PACAP38) modulates lymphocyte and macrophage functions: stimulation of adherence and opposite effect on mobility
- 1 December 1996
- journal article
- research article
- Published by Elsevier in Neuropeptides
- Vol. 30 (6) , 583-595
- https://doi.org/10.1016/s0143-4179(96)90042-6
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- The syntax of immune-neuroendocrine communicationImmunology Today, 1994
- Gene Expression of VIP Receptor in Rat LymphocytesBiochemical and Biophysical Research Communications, 1994
- Cell adhesion in the immune systemImmunology Today, 1993
- Type I receptors for PACAP (a neuropeptide even more important than VIP?)Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1993
- Stimulation of phagocytic function in mouse macrophages by neurotensin and neuromedin NJournal of Neuroimmunology, 1993
- Vasoactive intestinal peptide receptor antagonists in rat seminal vesicle membranesEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- N‐Formyl‐methionyl‐leucyl‐phenylalanine induced accumulation of inositol phosphates indicates the presence of oligopeptide chemoattractant receptors on circulating human lymphocytesFEBS Letters, 1989
- Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cellsBiochemical and Biophysical Research Communications, 1989
- Interaction of vasoactive intestinal peptide (VIP) with human peripheral blood lymphocytes: Specific binding and cyclic AMP productionGeneral Pharmacology: The Vascular System, 1986
- Retinal inhibits TPA activated, calcium-dependent, phospholipid-dependent protein kinase (“C” kinase)Biochemical and Biophysical Research Communications, 1983